Trial Profile
Clinical Trials Insight: 700027936
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2007
Price :
$35
*
At a glance
- Drugs Tegobuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 29 Oct 2007 New trial record.